Showing results (1-10 of 382) with videos related to
Sort By:
Pageof 39
Immunologic Research|May 6, 2014
A killer choice for cancer immunotherapyTobi L Schmidt, Robert S Negrin, Christopher H ContagNature Reviews. Immunology|May 26, 2006
In vivo imaging using bioluminescence: a tool for probing graft-versus-host diseaseRobert S Negrin, Christopher H ContagScience (New York, N.Y.)|March 25, 2006
Synergistic antitumor effects of immune cell-viral biotherapySteve H Thorne, Robert S Negrin, Christopher H ContagMethods in Molecular Medicine|August 2, 2007
Methods for imaging cell fates in hematopoiesisJennifer Duda, Mobin Karimi, Robert S Negrin, et al.Methods (San Diego, Calif.)|September 6, 2003
Evaluation of effector cell fate and function by in vivo bioluminescence imagingMatthias Edinger, Petra Hoffmann, Christopher H Contag, et al.Journal of Cellular Biochemistry. Supplement|January 29, 2003
Understanding immune cell trafficking patterns via in vivo bioluminescence imagingStefanie Mandl, Christoph Schimmelpfennig, Matthias Edinger, et al.Molecular Imaging and Biology|November 23, 2014
[99mTc]Annexin V-128 SPECT Monitoring of Splenic and Disseminated Listeriosis in Mice: a Model of Imaging SepsisJonathan W Hardy, Zoia Levashova, Tobi L Schmidt, et al.Cancer Research|October 18, 2002
Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3Christian Scheffold, Martin Kornacker, Yolanda C Scheffold, et al.Blood|October 24, 2002
Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imagingMatthias Edinger, Yu-An Cao, Michael R Verneris, et al.Molecular Imaging|May 15, 2004
Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcomeStefanie J Mandl, Carina Mari, Matthias Edinger, et al.Pageof 39